While the majority of cancer cells utilize both aerobic glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) to generate energy, overexpression of HER2 has been demonstrated to augment glycolysis, manifested by increased glucose uptake and lactate production—concomitant with a reduction in oxygen consumption in breast cancer models [11]. The gene discussed is ERBB2; the disease is cancer.